The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients — Daehoon Kim (2019) | RDL Network
The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients
Article 2019 en
Authors
DK
Daehoon Kim
PY
Pil‐Sung Yang
EJ
Eunsun Jang
Abstract
1 min read
In an adherence level-dependent fashion, adherent use of NOAC showed better clinical outcomes without increasing bleeding risk. Maintaining ≥90% of adherence optimizes effectiveness of NOAC therapy without compromising its safety.
Tatjana Potpara, Bogdan Markovic, Marek Grygier, Simonetta Genovesi, Apostolos Tzikas, Serge Bovéda, Jens Erik Nielsen‐Kudsk, Giuseppe Boriani, Professor Gregory Lip, A. John Camm
Discussion(0)
No comments yet. Be the first to comment.